GlaxoSmithKline
GSK China scandal leads to staff conflict
March 11, 2015Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked
Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …
GlaxoSmithKline in major opium deal
March 5, 2015Sales and Marketing GSK, GlaxoSmithKline, Sun Pharma, opium, tasmania
GSK is to sell its opiates business to Sun Pharmaceuticals for an undisclosed amount, the two companies have announced. The …
GlaxoSmithKline announces board changes early
February 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Tom de Swaan, christopher gent, sir philip hampton
GlaxoSmithKline has confirmed that Sir Christopher Gent will step down early as chairman of GSK in May to be succeeded …
GSK buys bacteria vaccine firm
February 11, 2015Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines
GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …
GSK blames respiratory woes as sales drop
February 5, 2015Sales and Marketing Advair, GSK, GlaxoSmithKline, HIV, ViiV, Witty, anoro ellipta, breo, lovaza, q4, sales
GlaxoSmithKline’s respiratory business has been flagged as the key factor in the firm’s fourth quarter financial misfortunes, as its total …
Gavi pledges $300 million for Ebola vaccines
December 12, 2014Manufacturing and Production, Sales and Marketing GAVI, GSK, GlaxoSmithKline, J&J, JJ, Merck, Vaccine, WHO, newlink
The global vaccines alliance Gavi has committed to buying Ebola vaccines as soon as the World Health Organization recommends one …
ABPI and BIA establish new manufacturing partnership
September 23, 2014Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip
The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …
Pharma firms give researchers access
July 22, 2014Research and Development, Sales and Marketing AstraZeneca, GlaxoSmithKline, Janssen R&D, MRC, Pfizer, Takeda, UCB, lilly, research, virtual library
UK researchers are to gain access to compounds from seven pharma companies in a partnership with the Medical Research Council …
Pharma facility news in brief
November 18, 2013Manufacturing and Production Actavis, Bend Research and WuXi PharmaTech, China Pharma, GlaxoSmithKline, manufacturing, nibs
GlaxoSmithKline is planning to boost in-house production of pharmaceuticals in India by building a brand new facility with an investment …
GSK loses Tyverb patent
August 6, 2013Sales and Marketing Cancer, GSK, GlaxoSmithKline, Tyverb
GlaxoSmithKline has received a knockback from authorities in India, who have revoked the patent on its breast cancer drug Tyverb. …
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
GSK’s Trobalt launched in UK
May 25, 2011Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine
GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …
European recommendation for GSK’s lupus drug Benlysta
May 23, 2011Sales and Marketing Benlysta, CHMP, GlaxoSmithKline, Lupus
GlaxoSmithKline’s first-in-class lupus drug Benlysta has been given a major boost by regulators in the European Union. The European Medicines …
GSK takes lead role in UK personalised medicine programme
May 20, 2011Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine
The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
GSK and AZ collaborate on translational research centre
May 12, 2011Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research
The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …
Latest content
FibroFind appoints Lee Borthwick as CEO
